{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:52:43Z","timestamp":1773456763869,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/bf03346476","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T22:01:47Z","timestamp":1396044107000},"page":"406-410","source":"Crossref","is-referenced-by-count":15,"title":["The metabolic syndrome is not associated with homocysteinemia: The Persian Gulf Healthy Heart Study"],"prefix":"10.1007","volume":"32","author":[{"given":"I.","family":"Nabipour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Vahdat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Assadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Moradhaseli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Obeidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Sanjdideh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346476_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131: 363\u201375.","journal-title":"Ann Intern Med"},{"key":"BF03346476_CR2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/diacare.24.8.1403","volume":"24","author":"JB Meigs","year":"2001","unstructured":"Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. The Framingham Off spring Study. Diabetes Care 2001, 24: 1403\u201310.","journal-title":"Diabetes Care"},{"key":"BF03346476_CR3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2006.03.010","volume":"55","author":"J Bjorck","year":"2006","unstructured":"Bjorck J, Hellgren M, Rastam L, Lindblad ULF. Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: The Skaraborg project. Metabolism 2006, 55: 1007\u201313.","journal-title":"Metabolism"},{"key":"BF03346476_CR4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/meta.2000.6256","volume":"49","author":"V Fonseca","year":"2000","unstructured":"Fonseca V, Dicker-Brown A, Ranganathan S, et al. Effects of a highfat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 2000, 49: 736\u201341.","journal-title":"Metabolism"},{"key":"BF03346476_CR5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0026-0495(03)00262-2","volume":"52","author":"M Oron-Herman","year":"2003","unstructured":"Oron-Herman M, Rosenthal T, Sela BA. Hyperhomocysteinemia as a component of syndrome X. Metabolism 2003, 52: 1491\u20135.","journal-title":"Metabolism"},{"key":"BF03346476_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/jme.0.0270085","volume":"27","author":"S Najib","year":"2001","unstructured":"Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 2001, 27: 85\u201391.","journal-title":"J Mol Endocrinol"},{"key":"BF03346476_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1677\/jme.1.01581","volume":"34","author":"S Najib","year":"2005","unstructured":"Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. J Mol Endocrinol 2005, 34: 119\u201326.","journal-title":"J Mol Endocrinol"},{"key":"BF03346476_CR8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.33549\/physiolres.930745","volume":"55","author":"F Tanrikulu-Kilic","year":"2006","unstructured":"Tanrikulu-Kilic F, Bekpinar S, Unlucerci Y, Orhan Y. Insulin resistance is not related to plasma homocysteine concentration in healthy premenopausal women. Physiol Res 2006, 55: 285\u201390.","journal-title":"Physiol Res"},{"key":"BF03346476_CR9","first-page":"719","volume":"86","author":"IF Godsland","year":"2001","unstructured":"Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001, 86: 719\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346476_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0021-9150(98)00067-7","volume":"139","author":"EJ Giltay","year":"1998","unstructured":"Giltay EJ, Hoogveen EK, Elbers JMH, Gooren LJG, Asscheman H, Stehouwer CDA. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy non-obese subjects. Atherosclerosis 1998, 139: 197\u20138.","journal-title":"Atherosclerosis"},{"key":"BF03346476_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/oxfordjournals.epirev.a017978","volume":"20","author":"AD Liese","year":"1998","unstructured":"Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndromes: an epidemiologic perspective. Epidemiol Rev 1998, 20: 157\u201372.","journal-title":"Epidemiol Rev"},{"key":"BF03346476_CR12","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","volume":"27","author":"ES Ford","year":"2004","unstructured":"Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004, 27: 2444\u20139.","journal-title":"Diabetes Care"},{"key":"BF03346476_CR13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/diacare.27.4.978","volume":"27","author":"Y Liao","year":"2004","unstructured":"Liao Y, Kwon S, Shaughnessy S, et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004, 27: 978\u201383.","journal-title":"Diabetes Care"},{"key":"BF03346476_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/met.2006.4.185","volume":"4","author":"JM Garcin","year":"2006","unstructured":"Garcin JM, Cremades S, Garcia-Hejl C, et al. Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome? Metab Syndr Relat Disord 2006, 4: 185\u201395.","journal-title":"Metab Syndr Relat Disord"},{"key":"BF03346476_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-2-6","volume":"2","author":"R Gillum","year":"2003","unstructured":"Gillum R. Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American Men: The Third National Health and Nutrition Examination Survey. Nutrition J 2003, 2: 6.","journal-title":"Nutrition J"},{"key":"BF03346476_CR16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1507\/endocrj.K07E-018","volume":"54","author":"EJ Rhee","year":"2007","unstructured":"Rhee EJ, Hwang ST, Lee WY, et al. Relationship between metabolic syndrome categorized by newly recommended by international diabetes federation criteria with plasma homocysteine concentration. Endocrine J 2007, 54: 995\u20131002.","journal-title":"Endocrine J"},{"key":"BF03346476_CR17","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection","year":"2001","unstructured":"Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486\u201397.","journal-title":"JAMA"},{"key":"BF03346476_CR18","unstructured":"Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code manual of electrocardiographic findings. Bristol: John Wright, 1982."},{"key":"BF03346476_CR19","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2005.11.010","volume":"97","author":"SM Haffner","year":"2006","unstructured":"Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006, 97 (Suppl): 3A\u201311A.","journal-title":"Am J Cardiol"},{"key":"BF03346476_CR20","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","volume":"109","author":"PM Ridker","year":"2004","unstructured":"Ridker PM, Wilson WF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004, 109: 2818\u201325.","journal-title":"Circulation"},{"key":"BF03346476_CR21","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1515\/CCLM.2007.358","volume":"45","author":"D Liao","year":"2007","unstructured":"Liao D, Yang X, Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med 2007, 45: 1652\u20139.","journal-title":"Clin Chem Lab Med"},{"key":"BF03346476_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/01.RES.0000243583.39694.1f","volume":"99","author":"D Liao","year":"2006","unstructured":"Liao D, Tan H, Hui R, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Cir Res 2006, 99: 565\u20136.","journal-title":"Cir Res"},{"key":"BF03346476_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajcn\/73.3.613","volume":"73","author":"PF Jacques","year":"2001","unstructured":"Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determination of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001, 73: 613\u201321.","journal-title":"Am J Clin Nutr"},{"key":"BF03346476_CR24","volume-title":"Evaluation of the behavioral risk factor surveillance system (BRFSS) as a source of national estimates for selected health risk behaviors: Final Report","author":"Battelle Memorial Institute.","year":"1999","unstructured":"Battelle Memorial Institute. Evaluation of the behavioral risk factor surveillance system (BRFSS) as a source of national estimates for selected health risk behaviors: Final Report. Baltimore, Md: Battelle Memorial Institute, 1999."},{"key":"BF03346476_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00001648-199309000-00012","volume":"4","author":"M Serdula","year":"1993","unstructured":"Serdula M, Coates R, Byers T, et al. Evaluation of a brief telephone questionnaire to estimate fruit and vegetable consumption in diverse study populations. Epidemiology 1993, 4: 455\u201363.","journal-title":"Epidemiology"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346476\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T16:26:44Z","timestamp":1689092804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BF03346476"],"URL":"https:\/\/doi.org\/10.1007\/bf03346476","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}